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7. Reactivation of Mycobacterium 
tuberculosis as evidenced by 
fingerprinting 
Sujatha Narayanan 
Department of lmmunology 
Tuberculosis Research Centre 
Chetput, Chennai-603 031 
Tuberculosis (TB) has remained in the forefront among all the infectious diseases and it has 
been responsible for a high rate of mortality and morbidity around the world especially in the 
developing countries. The co-existence of HIV/TB has substantial impact on global 
epidemiology of TB The identification of specific strains involved in the spread of infection 
gains great significance owing to drastic changes in the global epidemiology of TB 
TB is the most common opportunistic infection in people living with HIV. As the Human 
immunodeficiency virus (HIV) breaks down the immune system, HIV infected people are at 
increased risk of TB. HIV infection is the single strongest risk factor for progression of TB 
infection to TB disease. Without HIV, the lifetime risk of developing TB disease in TB infected 
people is 10% but the annual risk of TB infection in HIV patients is 10%. Mycobacterium 
tuberculosis accelerates progress of HlV to AIDS. 
Tuberculosis disease develops in an individual due to progression of latent or primary infection, 
exogenous reinfection or endogenous reactivation. It is estimated that one third of the world's 
population is latently infected. Aoproximately 5-10% of the latently infected individuals may 
subsequently develop active tuberculosis during their life time. Host and microbial factors 
play a role in maintenance and progression of latent primary infection. 
Even after the patients have undergone complete treatment they can come down with 
tuberculosis disease again. In the past it was difficult to understand whether the patient has 
relapsed due to exogenous reinfection or endogenous reactivation. With the availability of 
molecular tools it is possible to identify the exogenous infection from endogenous reactivation. 
Controversy prevails regarding the relative importance of endogenous reactivation and 
exogenous reinfection as the cause of recurrent tuberculosis. Monitoring the control of 
tuberculosis by epidemiological information is very important especially in HIV/TB patients 
who tend to acquire reinfection frequently because of their weak immune system. Molecular 
epidemiology car help in identifying exogenous reinfection and this data combined with drug 
susceptibility results would accelerate the treatment of HIV/TB patients with effective 
chemotherapy. 
Restriction Fragment Length Polymorphism (RFLP) with the widely reported IS6110 probe 
has been considered an excellent tool. But the RFLP study conducted at TRC, South India 
using IS6110 revealed that 40% of south India strains2 carried single copy of IS6110 and 2- 
3% of the strains carry no IS6110 copy. Hence it becomes imperative to use an alternate 
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probe, like the direct-repeat (DR) probe, which is a DR element from M. bovis BCG to 
overcome the limitations of IS6110. We have used the DR probe to fingerprint isolates 
obtained from patients pretreatment and after a relapse to determine the frequency of 
exogenous reinfection versus the rate of endogenous reactivation in Madras in southern 
India. 
Comparison of pretreatment and post-treatment isolates in an ubran clinical 
and laboratory setting 
The pretreatment and relapse isolates of M. tuberculosis used in the study were obtained 
from patients with pulmonary tuberculosis included in controlled clinical trials conducted at 
Tuberculosis Research Centre. The isoloates originated from 52 patients who had undergone 
short-course Chemotherapy for 6 or 8 months. The initial isolate was obtained before starting 
treatment and the subsequent isolate was obtained after stopping treatment. Patients with 
quiescent disease were followed as long as 60 months by monthly sputum examination for 
upto 24 months from the start of treatment and at 3-month intervals thereafter in order to 
determine the stability of bacterlological quiescence and the relapse rates. A patient was 
classified as having had the bacteriological relapse (true relapse) if two or more positive 
cultures were obtained during a 6-month period. 
Coded samples of 44 pairs 
of clinical isolates were 
analysed by RFLP with DR. 
On analysis 30 different 
patterns were observed and 
the number of bands 
ranged from two to seven. 
On the basis of the number 
and molecular sizes of the 
bands similar RLFP patterns 
were grouped. Our 
laboratory based study 
showed that the patterns of 
69% of the isolates from 
patients with relapses 
matched those with 
pretreatment isolates, 
indicating that the rate of 
relapse caused by 
reactivation exceeds the rate 
of relapse caused by 
reinfection3. 
Fig. 1 : The DR RFLP patterns of the pre and post treatment 
isolates of patients 
lanes 1&2 represents pre & post treatment isolate of a patient and 
lanes 3&4 pre and post treatment isolate of the second patient 
and so on 
Similar studies4 were undertaken in a rural area of high prevalence in South India The study 
site was Tiruvllur District, where the world's biggest Mycobacterium bovis BCG trial was 
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conducted5. The total population of the study area is 580,000. The incidence of smear positive 
TB is 76 per 100,000 in the population6. The study subjects were all TB patients undergoing 
treatment according to the Revised National Tuberculosis Control Programme guidelines. Of 
437 culture positive patients 378 were available for RFLP analysis. Combined RFLP analysis 
with IS6110 & DR probes identified 236 (62%) patients with distinct patterns, and 142 (38%) 
patients were in one of the 35 clusters. More than 2 patients with identical RFLP patterns by 
IS6110 and DR probe were considered to be in a cluster. Totally there were 35 clusters in our 
first year study cluster denotes exogenous reinfection or ongoing transmission. The risk 
factors which were associated with clustering or ongoing transmission (though not satistically 
significant) are given below. Clustering was higher among patient above 45 years. House to 
house survey carried out in 10% of the population identified more patients in clusters. 
Furthermore, a majority of the patients who had a relapse and were in a cluster harbored an 
IS6110 single-copy strain. The risk factors not associated with clustering are multi-drug 
resistance, alcoholism, literacy and family size. 
The findings of this study suggest that the majority of the TB cases in south India occur 
predominantly due to reactivation. With the large scale introduction of directly observed 
treatment - short course (DOTS) in 1998 the transmission of infection is likely to be reduced 
due to the higher cure and lower relapse rates. However the reactivation of latent infection will 
continue to perpetuate new cases for years to come. The DOTS implementation should be 
sustained and supplemented by intensive and early case detection of TB, infection control 
measures to prevent TB transmission at outpatient and inpatient health facilities, and community 
education. 
The scenario has been 
different in HIV/TB. We have 
been following up the HIV/TB 
Centre. The positive cultures 
HlV/TB patients preliminary 
recurrent tuberculosis is 
more due to exogenous 
reinfection among HIV/TB. 
The study is in progress. 
Since exogenous reinfection has been that DOTS should be intensified. The other measure 
which could control TB in HIV patients is TB chemoprophylaxis of HIV positives and initiation 
of ART (anti retroviral therapy). The contribution of reinfection to the epidemiology and 
Fig. 2 : RFLP patterns of pre & post treated HIV/TB patients 
patients after treatment at 
Tuberculosis Research 
before treatment and after 
relapse have been analysed 
by RFLP using more than 2 
probes. In contast to non 
results indicate that the 
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pathogenesis of tuberculosis has important implications for tuberculosis control in India and 
other countries with a high burden of HIV and tuberculosis and deserves further study. 
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